Racial and ethnic differences in alcohol-associated aspartate aminotransferase and γ-glutamyltransferase elevation

Archives of Internal Medicine

Volumn 162, Issue 19, 2002, Pages 2236-2239

  Stewart, Scott H ^a  

^a ERIE COUNTY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ENZYME BLOOD LEVEL; ETHNIC GROUP; FEMALE; HUMAN; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AFRICAN AMERICANS; ALCOHOL DRINKING; ASPARTATE AMINOTRANSFERASES; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEALTH SURVEYS; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MEXICAN AMERICANS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; UNITED STATES;

EID: 0037190701     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.19.2236     Document Type: Article

References (16)

1. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res. 2001;25:1181-1187.
2. Singh GK, Hoyert DL. Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: Trends and differentials by ethnicity, socioeconomic status, and alcohol consumption. Hum Biol. 2000;72:801-820.
3. Dawson DA, Grant BF, Chou SP, Pickering RP. Subgroup variation in US drinking patterns: Results of the 1992 National Longitudinal Alcohol Epidemiologic Study. J Subst Abuse. 1995;7:331-344.
4. Cohen JA, Kaplan MM. The SGOT/SGPT ratio: An indicator of alcoholic liver disease. Dig Dis Sci. 1979;24:835-838.
5. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94: series 1: Programs and collection procedures. Vital Health Stat 1. 1994;No. 32:1-407.
6. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology. 1989;9:193-197.
7. Mathiesen UL, Franzen LE, Fryden A, Foberg U, Bodemar G. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients. Scand J Gastroenterol. 1999;34:85-91.
8. Manolio TA, Burke GL, Savage PJ, et al. Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study. Clin Chem. 1992;38:1853-1859.
9. Burns CJ, Boswell JM, Olsen GW. Liver enzyme activity and body mass index. J Occup Environ Med. 1996;38:1248-1252.
10. Chao YC, Wang LS, Hsieh TY, Chu CW, Chang Y, Chu HC. Chinese alcoholic patients with esophageal cancer are genetically different from alcoholics with acute pancreatitis and liver cirrhosis. Am J Gastroenterol. 2000;95:2958-2964.
11. Tait BD, Mackay IR. HLA and alcoholic cirrhosis. Tissue Antigens. 1982;19:6-10.
12. Hines LM, Stampfer MJ, Ma J, et al. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction. N Engl J Med. 2001;344:549-555.
13. Karasawa T, Kushida T, Shikata T, Kaneda H. Morphologic spectrum of liver diseases among chronic alcoholics: A comparison between Tokyo, Japan and Cincinnati, USA. Acta Pathol Jpn. 1980;30:505-514.
14. Bosron WF, Lumeng L, Li TK. Genetic polymorphism of enzymes of alcohol metabolism and susceptibility to alcoholic liver disease. Mol Aspects Med. 1988; 10:147-158.
15. Li TK, Bosron WF. Distribution and properties of human alcohol dehydrogenase isoenzymes. Ann N YAcad Sci. 1987;492:1-10.
16. Agarwal DP, Goedde HW. Genetic variation in alcohol metabolizing enzymes: Implications in alcohol use and abuse. Prog Clin Biol Res. 1987;241:121-139.